Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses

Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses

0:00
19 September 2007

Georg Härter REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 GEORG HÄRTER, University Hospital, Ulm For patients with multiple myeloma b

Georg Härter

Georg Härter

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007GEORG HÄRTER, University Hospital, UlmFor patients with multiple myeloma being treated with the proteasome inhibitor bortezomib, doctor’s should be wary of viral reactivation – and they should give antiviral prophylaxis in all cases. This finding was unveiled at ICAAC byGeorg Härterfrom the University Hospital in Ulm, and he shared his data with Derek Thorne.